The Many Lanes of Biopharma - SOLD OUT


Started your career in R&D and wondering what other paths might be possible? Or curious about where your scientific training can take you beyond the bench? 

Join Soufflé Therapeutics and WEST for a panel conversation with industry professionals who began in R&D and have since moved into diverse areas such as AI, Business Development, and Regulatory Affairs. Hear how they made the transition, what skills carried over, what they learned along the way, and what they wish they had known earlier.

Whether you're happy at the bench, considering a career pivot, or simply curious about the many paths within biopharma, this conversation will offer practical insights and inspiration for navigating your career.  Sam Bhattacharyya, Senior Scientist, Muscle Biology at Soufflé Therapeutics will moderate the panel discussion.

 

Panelists include

  • Daisy Lam-McMahon, Senior Regulatory Affairs Specialist at Beam Therapeutics
  • Edward Miracco, Head of Enterprise AI Enablement at Moderna
  • Claire Rhodes, Director, US Commercial / Marketing, Neurology at Ionis Pharmaceuticals, Inc.

 

 

Date and Time:  
November 10, 2026
6:00-8:00 PM 

   6:00-6:15pm: Registration, food, networking
   6:15-7:30pm: Panel
   7:30-8:00pm: Optional Networking

Location:  
Soufflé Therapeutics, 250 Arsenal St, Watertown, MA 02472

 

Cost:   
Members: $15; Non-Members: $30

Given our mission is to promote women's development in STEM we would like to offer a free spot in our workshops to those in transition between jobs or who cannot afford the ticket price. Please contact [email protected] if you qualify.

 

This event is sold out and is no longer taking registrations. 

 

Panelist Bios

Daisy Lam-McMahon is a regulatory affairs professional with a background spanning biomedical research, gene editing research, and CMC regulatory strategy. At Beam Therapeutics, she supports global regulatory dossiers for genomic medicines and cell therapies, evaluates CMC changes, and contributes to regulatory processes and submissions. She holds a master’s degree in Biomedical Forensic Sciences from Boston University School of Medicine and a bachelor’s degree in Microbiology and Immunology from the University of Miami.

Edward Miracco is Head of Enterprise AI Enablement at Moderna. Edward is a scientist and technologist driven by curiosity and a bias for action. His career bridges molecular biology and digital systems, spanning mechanistic enzymology, RNA and oligo chemistry, NMR and cryo-EM structural biochemistry, mRNA process and LNP development, and digital transformation. At Moderna, he helped build the mRNA process platform that enabled the COVID-19 vaccine, led global release and stability operations through mRNA-1273 EUA, and later advanced strategic partnerships and AI-enabled Research and Development. He holds a Doctor of Philosophy (PhD) in Mechanistic Enzymology of RNA Editing Enzymes from University of Delaware.

Claire Rhodes is Director, Commercial/Marketing for US Neurology at Ionis, where she leads commercial strategy for ZANVASTRO in Alexander Disease (AxD). She brings extensive experience in rare disease, having held global commercial and U.S. marketing roles at Biogen across both marketed products and launch-stage assets. Throughout her career, Claire has led innovative disease education, patient engagement, and launch readiness initiatives focused on improving diagnosis, treatment adoption, and patient outcomes. Prior to Biogen, she held research roles at bluebird bio and Boston Children's Hospital. Claire earned her MBA in Health Sector Management from Boston University and is based in the Boston area.

 

 

Thank you to Soufflé Therapeutics for sponsoring this event.